Feature | March 04, 2015

Greater Consensus Needed on Breast Cancer Overdiagnosis

Very different estimates are blocking effective communication about breast cancer overdiagnosis, says expert

breast cancer, overdiagnosis, mammography, Alexandra Barratt, BMJ

March 4, 2015 — More than any other debate about overdiagnosis, the discussion of breast cancer has spilt from the pages of the specialist medical press into the public domain, argues a public health expert in The BMJ this week.

In 2012, prompted by increasing debate about overdiagnosis, an independent United Kingdom panel estimated that about 19 percent of breast cancers diagnosed among women invited to mammogram screening were in fact overdiagnosed (they would have been harmless). But other estimates have been higher (up to 50 percent) or lower (less than 5 percent).

Achieving consensus seems unlikely in the short term but resolution should be a high priority so that women can be given objective, balanced and uncontested information, writes Alexandra Barratt, Ph.D., MPH, professor of public health at the University of Sydney.

This article is part of a series on overdiagnosis looking at the risks and harms to patients of expanding definitions of disease and increasing use of new diagnostic technologies.

Breast cancer is the most common cancer in women worldwide. Early trials reported that screening reduced the risk of dying from breast cancer by around 30 percent in women over 50 and led to publicly funded mammography screening programs in many countries in the 1980s and 90s.

Although this has led to large increases in detection of early breast cancer, rates of advanced cancer have declined only slightly or remained relatively stable, suggesting that mammography screening is detecting low risk or non-progressing breast cancer that would never have become life-threatening.

In the NHS screening program, 99 percent of women with screen-detected breast cancer undergo surgery, and around 70 percent also have radiotherapy and hormone therapy. If around 20 percent of these breast cancers are overdiagnosed, then about 20 percent of these women are undergoing treatments to "cure" a disease which they would never had had without screening, explains Barratt.

She also argues to think twice before introducing new breast imaging technologies, such as tomosynthesis (3-D mammography) or extending screening to older and younger women, until incremental net benefit to women has been demonstrated in high-quality studies.

Changing screening policy "should be based on demonstrated ability to achieve equivalent benefit to harm ratios and not on the assumption that increased detection will achieve a net benefit."

Lastly, she calls for more balanced information for women and says participation targets should not be set and should not be regarded as a marker of health service quality.

"Breast cancer research has led the way in developing awareness of the potential harms of overdiagnosis and overtreatment among asymptomatic people who participate in cancer screening programs," concludes Barratt. "Increasing awareness and understanding of overdiagnosis in relation to the early detection of lung and thyroid cancers, as well as breast and prostate cancers, is needed and should be prioritized in public communication initiatives."

For more information: www.bmj.com

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
VolparaDensity With Tyrer-Cuzick Model Improves Breast Cancer Risk Stratification
News | Breast Density | May 22, 2019
Research has demonstrated use of Volpara Solutions' VolparaDensity software in combination with the Tyrer-Cuzick Breast...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
AI Detects Unsuspected Lung Cancer in Radiology Reports, Augments Clinical Follow-up
News | Artificial Intelligence | May 20, 2019
Digital Reasoning announced results from its automated radiology report analytics research. In a series of experiments...
New Study Evaluates Head CT Examinations and Patient Complexity
News | Neuro Imaging | May 17, 2019
Computed tomography (CT) of the head uses special X-ray equipment to help assess head injuries, dizziness and other...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Icon Launches New Clinical Trial Patient Engagement Platform
Technology | Patient Engagement | May 14, 2019
Icon plc announced the release of its web-based clinical trial patient engagement platform, to provide patients with...
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
News | MRI Breast | May 09, 2019
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast...